Take A Look At Technologies And Business Plans From 234 Biotech Companies


San Diego, Calif. (June 12, 2001) – The Biotechnology Industry Organization is hosting the industry’s largest lineup of presenting companies at the Third Annual International Investor & Partnering Forum during the BIO 2001 meeting in San Diego. The event offers investors and potential corporate partners a chance to learn about exciting new companies developing products in healthcare, agricultural, industrial and environmental biotechnology.

More than 230 companies will describe their technologies, products and business plans. Each will give a 15-minute presentation and will then adjourn for a breakout session with audience members who would like to hear more. Presentations are grouped by category to make it more efficient to learn about companies in specific areas. In addition to the presentations, more than 1,000 individual partnership meetings between companies have been scheduled.

“The Investor & Partnering Forum will provide an opportunity to evaluate early-stage companies with promising new technologies and products, as well as a closer look at mid- and late-stage companies that have products in advanced testing,” said Morrie Ruffin, BIO’s vice president for business development and emerging companies. About half the presenting companies are privately held and half are publicly traded.

The forum will take place at the Sails Pavilion, San Diego Convention Center, from Monday, June 25, through Wednesday, June 27.

Sixteen countries are represented, and more than 80 of the companies hail from outside the U.S., including 25 from Canada; 21 from Germany; 10 each from France and the U.K.; four each from Australia and Switzerland; two each from Finland, the Netherlands and Sweden; and one each from Austria, Belgium, Denmark, Israel, Japan (MedGene, the forum’s first-ever Japanese presenter), and Taiwan.

Registration for the International Investor & Partnering Forum is free for participants who also register for BIO 2001. For up-to-date schedule information and to register to attend the forum, please go to For BIO 2001 information, visit

International Investor & Partnering Forum Presentation groupings are as follows:

AgBio, Bioproduction, Blood Products, Biomaterials, CNS, Supply/Services, Diagnostics, Reproductive, Metabolic Diseases

Cancer, Drug Delivery, Inflammation, Infectious Diseases

Enabling Technology, Drug Discovery, Genomics, Proteomics, Bioinformatics

Biotechnology Industry OrganizationBIO represents more than 950 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.

# # #